首页> 美国卫生研究院文献>other >Hydroxypropyl Methylcellulose-based Controlled Release Dosage by Melt Extrusion and 3D Printing: Structure and Drug Release Correlation
【2h】

Hydroxypropyl Methylcellulose-based Controlled Release Dosage by Melt Extrusion and 3D Printing: Structure and Drug Release Correlation

机译:通过熔融挤出和3D打印的羟丙基甲基纤维素基控释剂量:结构和药物释放相关性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of this study was to develop a new approach for fabrication of zero order release of active pharmaceutical ingredients (APIs) using hot-melt extrusion (HME) and 3D printing technology to generate tablets with specific 3D structures. By correlating the geometry of the 3D printed tablets with their dissolution and drug release rates, mathematical models that have been developed to describe drug release mechanisms were also studied. Acetaminophen was used as a model drug, and Benecel™ hydroxypropyl methylcellulose (HPMC) E5 and Soluplus® were used to formulate nine fuse depositional 3D-printed tablets with different inner core fill densities and outside shell thicknesses. This work reports the successful fabrication of solid-dispersion filaments with an API dispersed in HPMC based matrix via HME technology, and the production of zero order controlled release tablets with different 3D structures (tablets #3, 5, 6, and 9) using a 3D printer.
机译:这项研究的目的是开发一种利用热熔挤出(HME)和3D打印技术制造具有特定3D结构的片剂的零级释放活性药物成分(API)的新方法。通过将3D打印药片的几何形状与其溶解度和药物释放速率相关联,还研究了描述药物释放机理的数学模型。以对乙酰氨基酚为模型药物,使用Benecel™羟丙基甲基纤维素(HPMC)E5和Soluplus ®配制9种不同内芯填充密度和外壳厚度的熔融沉积3D打印片剂。这项工作报告了通过HME技术成功制造出具有分散在基于HPMC的基质中的API的固体分散长丝,以及使用不同的3D结构(片剂#3、5、6和9)生产零级控释片剂的方法。 3D打印机。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号